<DOC>
	<DOCNO>NCT01540487</DOCNO>
	<brief_summary>The aim trial ass relative bioavailability fix dose combination tablet linagliptin metformin compare administration two single tablet ( linagliptin metformin ) Chinese subject . The availability fix dose combination tablet expect significantly enhance patient ` compliance antidiabetic treatment. , particular concern frequent polypharmacy diabetic patient .</brief_summary>
	<brief_title>Pharmacokinetics Fixed Dose Combination ( FDC ) Tablets Linagliptin /Metformin</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male female subject Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>